<b>Gapping down</b><br/><u>In reaction to disappointing earnings/guidance:</u> TLAB -19.7%, REDF -7.7%, GWW -7.2%, STM -4.8%, WGOV -4.8%, PKG -4.8%, VMW -4.6%, COH -3.1%, TXN -2.5%, EMC -1.8%, AXP -1.8%, JNJ -1.3%, PLXT -1.1%, SANM -0.9%, MMM -0.9%, X -0.9%, VZ -0.6%.<br/><br/><u>M&A news:</u> DYN -5.5% (ticking lower, announces expiration of open strategic alternatives process; board reaffirms recommendation that stockholders tender shares into the icahn tender offer).<br/><br/><u>Select financial related names showing weakness with European banks weighing on group following Spanish bank plans, UK GDP: </u> AIB -8.2%, LYG -4.6%, STD -3.3%, BBVA -2.8%, BCS -2.4%, DB -2%, HBC -1.3%, ING -1.3%, CS -1%, PUK -1.0%.<br/><br/><u>Select metals/mining stocks trading lower</u>: SWC -3.9%, PZG -3.5%, RIO -2.8%, GOLD -2.6%, GFI -2.5%, SLW -2.4%, BBL -2.1%, PAL -2.1%, AU -2.0%, TGB -1.8%, KGC -1.8%, FCX -1.7%, HL -1.6%, PAAS -1.5%, SSRI -1.5%, HMY -1.4%, GSS -1.2%.<br/><br/><u>Select oil/gas related names showing early weakness: </u>STO -1.9%, BP -1.8%, PXP -1.7%, TOT -1.6%, NOV -1.3%, RDS.A -1.3%, E -1.2%.<br/><br/><u>Select shipping names under pressure</u>: EGLE -8.2%, DRYS -3.8%, GNK -3.6% (downgraded to Hold at Deutsche Bank), NM -3.5%, EXM -3.3%.<br/><br/><u>Select drug names trading lower:</u> GSK -2.2%, AZN -1.9%, SNY -1.1%.<br/><br/><u>Other news: </u> HDY -24.1% (Hyperdynamics announces termination of letter of intent and updates plans), EK -6.1% (receives notice of initial determination in ITC patent infringement Action Against Apple and Research In Motion), UL -3.4% (Indian unit Hindustan Unilever reported earnings), SNN -2.6% (still checking), CCL -2.6% (still checking), VOD -2% (lower following cautious mention in financial newspaper), FDO -1% (files for a sr debt securities shelf offering for an indeterminate amount), .<br/><br/><u>Analyst comments: </u>ADBE -2.1% (downgraded to Neutral from Overweight at Piper Jaffray), CAM -1.8% (downgraded to Neutral from Overweight at HSBC Securities), OLN -1.6% (initiated with a Sell at UBS), XCO -1% (downgraded to Sector Perform from Outperform at RBC Capital), SSCC -0.7% (downgraded to Underperform from Outperform at BMO Capital).